US Stock · Smart-money analysis

BIIB Biogen Inc.

TREND LEADER
Price
$204.54
1D
-2.10%
5D
+2.71%
20D
+2.95%
Conviction
76
Buy Score
70
Signal
TREND LEADER
Phase
WATCHING
RVOL
0.3×
RSI
42.8
52w range
$121.05 – $219.72
Sector
Healthcare

BIIB (Biogen Inc.) is a US stock trading at $204.54, -2.10% on the day. mdvin's smart-money engine places it in the WATCHING operator phase, with a GRINDER accumulation style. Current conviction is 76/100 and the Buy Score is 70. The active signal is TREND LEADER. It has ignited 2 time(s) in the last 90 sessions, paying off 20% of the time (typical run +1.2%). Reversal/trap risk is graded LOW. On fundamentals it looks fair value (quality grade C, analyst upside +10.60%).

Fundamentals

P/E
21.9
Fwd P/E
12.3
PEG
4.04
ROE
7.7%
Valuation
FAIR VALUE
Quality
C
Analyst upside
+10.60%
Next earnings
2026-07-29
Live deep-dive → Open chart Full screener

Snapshot updated daily; open the live deep-dive for the latest. Educational only — not investment advice.